drugset / Trial / NCT00106002
Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purposes of this study are to determine whether pemetrexed can help patients with metastatic (cancer that has spread to other parts of the body) breast cancer, to determine any side effects that may be associated with the drug, to determine how much pemetrexed should be given to patients, and to collect DNA for future research regarding metastatic breast cancer. The collection of DNA is optional to the patient.
Timeline
- Start
- 2005-04
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | 600 mg/m2 | Intravenous |